Terms: = Gastric cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Clinical Outcome
11 results:
1. Efficacy of the Oral Administration of Maltodextrin Fructose Before Major Abdominal Surgery: A Prospective, Multicenter clinical Study.
Qin H; Ji J; Miao Y; Liu T; Zhao D; Jia Z; Jiang J; Liu J; Li Q; Ji X; Fu W; Lou D; Xia W; Li N
World J Surg; 2022 Sep; 46(9):2132-2140. PubMed ID: 35718790
[TBL] [Abstract] [Full Text] [Related]
2. Effects of perioperative enhanced recovery after surgery pathway management versus traditional management on the clinical outcomes of laparoscopic-assisted radical resection of distal gastric cancer: study protocol for a randomized controlled trial.
Tian Y; Cao S; Li L; He Q; Xia L; Jiang L; Ding Y; Wang X; Wang H; Mao W; Hui X; Shi Y; Zhang H; Chu X; Kehlet H; Zhou Y
Trials; 2020 May; 21(1):369. PubMed ID: 32357913
[TBL] [Abstract] [Full Text] [Related]
3. A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
Liu X; Guo W; Zhang W; Yin J; Zhang J; Zhu X; Liu T; Chen Z; Wang B; Chang J; Lv F; Hong X; Wang H; Wang J; Zhao X; Wu X; Li J
BMC Cancer; 2017 Mar; 17(1):188. PubMed ID: 28288572
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of serum levels of vascular endothelial growth factor and insulin-like growth factor-1 in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Oh SY; Kwon HC; Kim SH; Lee S; Lee JH; Graves CA; Camphausen K; Kim HJ
Chemotherapy; 2012; 58(6):426-34. PubMed ID: 23295255
[TBL] [Abstract] [Full Text] [Related]
5. Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer.
Sonnenblick A; Rottenberg Y; Kadouri L; Wygoda M; Rivkind A; Vainer GW; Peretz T; Hubert A
Med Oncol; 2012 Dec; 29(5):3035-8. PubMed ID: 22773040
[TBL] [Abstract] [Full Text] [Related]
6. Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
Wainberg ZA; Lin LS; DiCarlo B; Dao KM; Patel R; Park DJ; Wang HJ; Elashoff R; Ryba N; Hecht JR
Br J Cancer; 2011 Sep; 105(6):760-5. PubMed ID: 21811258
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.
Kwon HC; Roh MS; Oh SY; Kim SH; Kim MC; Kim JS; Kim HJ
Ann Oncol; 2007 Mar; 18(3):504-9. PubMed ID: 17322540
[TBL] [Abstract] [Full Text] [Related]
8. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.
Petrioli R; Sabatino M; Roviello F; Marrelli D; Nastri G; Marsili S; Correale P; Pozzessere D; Messinese S; De Martino A; Tani F; Marzocca G; Lorenzi M; Civitelli S; Tanzini G; Pinto E; Francini G
Hepatogastroenterology; 2005; 52(65):1626-30. PubMed ID: 16201130
[TBL] [Abstract] [Full Text] [Related]
9. [Two head and neck cancer patients who responded to chemotherapy consisting of only TS-1].
Mikami Y; Tsukuda M; Kawai S; Kagesato Y; Tanigaki Y; Horiuchi C; Mochimatsu I
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1473-7. PubMed ID: 14584280
[TBL] [Abstract] [Full Text] [Related]
10. Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
Konecny G; Untch M; Arboleda J; Wilson C; Kahlert S; Boettcher B; Felber M; Beryt M; Lude S; Hepp H; Slamon D; Pegram M
Clin Cancer Res; 2001 Aug; 7(8):2448-57. PubMed ID: 11489825
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
Amin MB; Ma CK; Linden MD; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1993 Oct; 100(4):428-32. PubMed ID: 8105676
[TBL] [Abstract] [Full Text] [Related]
